Results 201 to 210 of about 632,968 (345)

Pharmacokinetics and analgesic efficacy of fentanyl and buprenorphine in chicken embryos. [PDF]

open access: yesPLoS One
Truhlar L   +9 more
europepmc   +1 more source

Exploring the molecular mechanisms of Traditional Chinese Medicine components using gene expression signatures and connectivity map

open access: yesComput. Methods Programs Biomed., 2019
Minjae Yoo   +5 more
semanticscholar   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

The Accuracy of Dynamic Parameters for Prediction of Fluid Responsiveness in Elderly Patients with Septic Shock

open access: yesInternational Journal of General Medicine
Sittikorn Paphawin,1,* Pongdhep Theerawit,2,* Detajin Junhasavasdikul,3 Yuda Sutherasan3 1Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 2Division of Critical Care Medicine, Department of ...
Paphawin S   +3 more
doaj  

Identification and management of invasive mycoses in internal medicine: a road-map for physicians [PDF]

open access: bronze, 2014
Marco Falcone   +7 more
openalex   +1 more source

Analyzing the use of linking words in concept maps designed for pathophysiology learning in medicine

open access: gold, 2021
Nuno Neuparth   +11 more
openalex   +2 more sources

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Evidence map analysis of clinical studies on 42 commonly used oral Chinese patent medicines for the treatment of stable chronic obstructive pulmonary disease

open access: hybrid
J. Li   +14 more
openalex   +1 more source

Home - About - Disclaimer - Privacy